Insiders · Profile

Kreitzer Anatol

Chief Discovery Officer at MapLight Therapeutics. Filing since 15 Apr 2026. CIK 0002021238

Company
Date
Role
Action
Shares
Amount
Of holding
17 Jul 2026
Chief Discovery Officer
Sold on a plan
17,173
$645.72K
8.9%
16 Jul 2026
Chief Discovery Officer
Sold on a plan
9,056
$333.23K
4.5%
15 Jul 2026
Chief Discovery Officer
Sold on a plan
10,055
$366.94K
4.8%
27 Apr 2026
Chief Discovery Officer
Sold on a plan
45,422
$1.35M
17.7%
15 Apr 2026
Chief Discovery Officer
Sold at will
3,316
$88.24K
1.3%
5 decisions on file.